TTIC
BIIB icon

Tower Trust & Investment Company’s Biogen BIIB Stock Holding History

Tower Trust & Investment Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Sell
2,818
-50
-2% -$9.56K 0.37% 64
2026
Q1 		$526K Buy
2,868
+11
+0.4% +$2.03K 0.35% 72
2025
Q4 		$503K Sell
2,857
-43
-1% -$7.03K 0.32% 74
2025
Q3 		$406K Buy
2,900
+5
+0.2% +$676 0.27% 75
2025
Q2 		$364K Buy
2,895
+168
+6% +$20.9K 0.26% 76
2025
Q1 		$330K Buy
+2,727
New +$390K 0.27% 76

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Tower Trust & Investment Company's BIIB Position: Q2 2026 in Review

Tower Trust & Investment Company reduced its Biogen (BIIB) stake by 1.7% in Q2 2026, selling an estimated $9.56K and leaving 2,818 shares worth $609K. The position accounts for 0.37% of the portfolio, ranked #64.

Tower Trust & Investment Company first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Tower Trust & Investment Company held 2,818 shares of Biogen worth $609K as of Q2 2026.
  • Tower Trust & Investment Company sold 50 Biogen shares in Q2 2026, an estimated $9.56K.
  • Biogen made up 0.37% of Tower Trust & Investment Company's portfolio in Q2 2026, its #64 holding.
  • Tower Trust & Investment Company first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.